Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting publishing date : 2022 - 05 - 03 save search
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
Published: 2022-05-03 (Crawled : 14:20) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 17.94%
H: 2.52%
C: -5.18%
biotech meeting
Ocular Therapeutix™ To Present Pre-Clinical Data at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting
Published: 2022-05-03 (Crawled : 16:20) - ocutx.gcs-web.com
OCUL | News | $5.0 -1.48% -1.5% 2.3M
|
Health Technology
|
| O: 0.25%
H: 0.98%
C: 0.98%
pre-clinical ocular therapy preclinical
Shareholders approve all resolutions on the agenda of Tenaris’s Annual General Meeting
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
TS | $37.87 0.29% 0.0% 1.5M
|
Non-Energy Minerals
|
| O: 1.29%
H: 1.6%
C: 1.3%
Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis
Published: 2022-05-03 (Crawled : 21:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
hzn-4920 topline
UPDATE - Passage Bio to Present Updated Imagine-1 Study Clinical and Biomarker Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-03 (Crawled : 19:00) - globenewswire.com
PASG | News | $1.24 8.77% 8.06% 54K
|
Health Technology
|
| O: 1.02%
H: 12.63%
C: 12.63%
therapy biomarkers
Strong Shareholder Support for Barrick at Annual Meeting
Published: 2022-05-03 (Crawled : 19:00) - globenewswire.com
GOLD | $16.69 1.64% -0.66% 25M
|
Non-Energy Minerals
|
| O: 1.29%
H: 2.25%
C: 2.16%
GOLD | $16.69 1.64% -0.66% 25M
|
Non-Energy Minerals
|
| O: 1.29%
H: 2.25%
C: 2.16%
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
TNYA | $4.45 0.45% 0.45% 150K
|
|
| O: -0.21%
H: 0.58%
C: -3.05%
preclinical therapeutics therapy platform pre-clinical
Meet Our Advisors: Kate Bray
Published: 2022-05-03 (Crawled : 18:00) - fmbankva.com
FNCTF | News | $11.16 1.13% -20.84% 31
|
Communications
| Email alert
Add to watchlist
Press Release: Annual General Meeting of May 3, 2022
Published: 2022-05-03 (Crawled : 18:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
Chesapeake Utilities Corporation Announces Capacity Expansion to Meet Growing Customer Demand along Coastal Delaware and Maryland Capital Investment of $6.3 Million
Published: 2022-05-03 (Crawled : 15:00) - chpk.com
CPK | News | $105.67 -0.05% 0.0% 73K
|
Utilities
|
| O: -0.63%
H: 0.0%
C: 0.0%
expansion growing capacity corporation
Trevi Therapeutics to Present at Upcoming May Meetings
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
TRVI | $2.84 -3.4% -3.52% 170K
|
Health Technology
|
| O: -7.6%
H: 9.05%
C: 4.53%
therapeutics
Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2022 Annual Meeting
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: 4.37%
H: 7.79%
C: 7.73%
therapeutics therapy
INNOVATE Corp. Portfolio Company R2 Technologies Announces First Year Commercial Milestone and Clinical Data Presentation at Recent ASLMS Annual Meeting
Published: 2022-05-03 (Crawled : 13:00) - globenewswire.com
VATE | News 0 d | $0.5961 -2.28% 0.0% 120K
|
Information
|
| O: 2.01%
H: 3.44%
C: 2.3%
presentation milestone
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
RGNX | $15.885 1.57% 1.54% 360K
|
Health Technology
|
| O: 1.36%
H: 1.48%
C: -0.49%
therapy
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: 0.43%
H: 1.3%
C: -0.74%
nov03 treatment research trial phase 3
Omega Therapeutics to Unveil Preclinical Data on Epigenomic Programming of MYC with Epigenomic Controllers as a Promising Therapeutic Approach in Non-Small Cell Lung Cancer at the 25th Annual ASGCT Meeting
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 3.65%
H: 0.88%
C: -4.69%
preclinical therapeutics cancer pre-clinical
AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
AVRO | $1.21 0.83% 0.41% 54K
|
Health Technology
|
| O: 1.53%
H: 0.66%
C: -3.46%
preclinical pre-clinical
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.